Ahmed ClearPath
The World’s Leading Glaucoma Drainage Device
Established Clinical Data
Most studied glaucoma drainage device, with over 670 clinical publications
ABC Study Highlights Improved Safety With the Ahmed® Glaucoma Valve
The ABC study—the largest and longest prospective clinical trial comparing 2 aqueous shunts—found that while both implants had similar rates of surgical success at 5 years, the Baerveldt® Glaucoma Implant was associated with twice as many failures as the Ahmed® Glaucoma Valve (AGV) because of safety issues.
Aqueous Suppressant Therapy
Research demonstrated that early initiation of aqueous suppressant treatment after Ahmed® Glaucoma Valve implantation improves the success rate of the procedure, provides better IOP control, and reduces the likelihood of a hypertensive phase (HP). One main benefit of this technique is the
reduction in the IOP spike associated with the HP.4
Request for more information
Feel free to request for a call back if you are interested in any of our listed products. Our friendly advisers are more than happy to answer any queries that you may have!
